Christopher Eso

Medical Technology Venture Partners (MedTech Venture Partners) is a venture capital firm founded by Radu Cautis and Thomas Heinrich Glanzmann in 2017. The firm is headquartered in San Francisco, California.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Avid Bioservices, Inc. provides specialized cell cultures for biotechnology testing. Its services include cell line optimization, cell culture and purification process development, protein characterization, process optimization, scale-up and validation, cGMP clinical and commercial manufacturing, bulk filling, aseptic filling, analytical assay development, method qualification and validation, QC release and stability testing and regulatory strategy and submission. The company was founded by Steven W. King in 2001 and is headquartered in Tustin, CA.

Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ.